IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
Clinical trial NCT03401073 · COMPLETED
Trial details
- NCT number
- NCT03401073
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2022-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.